Insomnia and sleep characteristics in post COVID-19 fatigue: A cross-sectional case-controlled study.
Rauwerda, Nynke L, Kuut, Tanja A, Braamse, Annemarie M J et al. · Journal of psychosomatic research · 2024 · DOI
Quick Summary
This study looked at sleep problems in people with long COVID fatigue and compared them to people with ME/CFS. Researchers found that 64% of long COVID patients had clinically significant insomnia, and their sleep problems were closely linked to depression and age. While long COVID patients slept slightly less than ME/CFS patients on average, both groups struggled significantly with sleep quality and nighttime insomnia.
Why It Matters
This study clarifies that insomnia is a major, often under-recognized feature of post-COVID-19 fatigue that requires specific clinical attention. Because post-COVID-19 fatigue and ME/CFS share overlapping symptoms, understanding their distinct sleep profiles helps clinicians differentiate between conditions and tailor treatment appropriately for patients with either diagnosis.
Observed Findings
64% of post-COVID-19 fatigue patients met clinical insomnia criteria (ISI score ≥10) with mean severity of 11.46 (SD 5.7)
Insomnia severity was significantly associated with depressive symptoms (ß=0.49, p=0.006) and older age (ß=0.08, p=0.04)
Post-COVID-19 fatigue patients reported mean subjective sleep duration of 7.4 (1.0) hours with 82% sleep efficiency
Sleep duration was significantly shorter in post-COVID-19 fatigue versus ME/CFS patients (p=0.003, effect size d=0.58)
Most other sleep characteristics between post-COVID-19 and ME/CFS groups were similar and not clinically meaningful
Inferred Conclusions
Insomnia is highly prevalent and clinically significant in post-COVID-19 fatigue, warranting routine assessment and targeted treatment
Depression and age are key factors associated with insomnia severity in this population
While post-COVID-19 fatigue and ME/CFS share many features, distinct sleep duration patterns may help differentiate the conditions
Insomnia-focused cognitive-behavioral therapy should be considered as part of standard care for post-COVID-19 fatigue patients
Remaining Questions
Does treating insomnia specifically improve overall fatigue, functional outcomes, or quality of life in post-COVID-19 patients?
What This Study Does Not Prove
This study does not establish whether insomnia causes fatigue or whether fatigue causes insomnia—the temporal relationship remains unclear. The cross-sectional design cannot determine causality or whether treating insomnia will improve post-COVID fatigue symptoms. Additionally, findings are specific to these two patient groups and may not generalize to broader post-COVID populations.